To assess the role of CCL7 in DC recruitment upon GLI1 silencing in melanoma cells, moDCs cultured with RPMI, or CM from SSM2c cells transduced with LV-c or LV-shGLI1 were treated with neutralizing CCL7 antibody or IgG isotype matched control. This evidence concerns the gene GLI1 and melanoma.